Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.

Bleyer, Anthony J

Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. [electronic resource] - American journal of kidney diseases : the official journal of the National Kidney Foundation Nov 2008 - 1024; author reply 1025 p. digital

Publication Type: Letter; Comment

1523-6838

10.1053/j.ajkd.2008.06.034 doi


Acetates--therapeutic use
Calcium Compounds--therapeutic use
Chelating Agents--therapeutic use
Humans
Hyperphosphatemia--prevention & control
Polyamines--therapeutic use
Sevelamer